| 查看: 793 | 回复: 3 | |||
| 当前主题已经存档。 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
[交流]
Alkermes是一家什么公司
|
|||
|
请问各位大虾,Alkermes是一家什么公司啊?中文名叫什么喔,它在中国有销售处没有啊?主要生产什么呢? 谢谢各位啦!!!  |
回复此楼» 猜你喜欢
270分求调剂
已经有3人回复
-
材料调剂
已经有4人回复
-
材料0856 英一数二 323 求调剂
已经有13人回复
-
化学0703-一志愿211-338分求调剂
已经有5人回复
-
调剂
已经有4人回复
-
一志愿北交大材料工程总分358求调剂
已经有6人回复
-
求调剂
已经有6人回复
-
一志愿 江南大学 085602 化工专硕 338分求调剂
已经有8人回复
-
304求调剂（085602，过四级，一志愿985）
已经有15人回复
-
工科求调剂
已经有15人回复
4楼2008-07-13 21:59:58
★
karl2100(金币+1,VIP+0):多谢提供！
karl2100(金币+1,VIP+0):多谢提供！
|
基本资料 Alkermes, Inc. 88 Sidney Street Cambridge, MA 02139-4136 电话: 617-494-0171 传真: 617-494-9263 网站: http://www.alkermes.com Alkermes, Inc., a biotechnology company, develops products based on proprietary, extended-release and pulmonary drug delivery technologies. It has two commercial products that include RISPERDAL CONSTA, a long-acting atypical antipsychotic medication approved for use in schizophrenia, marketed worldwide by Janssen-Cilag; and VIVITROL, a once-monthly injectable medication approved for the treatment of alcohol dependence, marketed in the U.S. primarily by Cephalon, Inc. The company's pipeline comprises extended-release injectable, pulmonary, and oral products for the treatment of prevalent and chronic diseases, such as central nervous system disorders, addiction, and diabetes. Its development programs also include AIR Insulin, which is in Phase III clinical development stage for the treatment of diabetes; Exenatide LAR, a Phase II clinical development stage product for the treatment of type 2 diabetes; a Phase I/II clinical study product, ALKS 29, for the treatment of alcohol dependence; a Phase IIa clinical study product, ALKS 27, for the treatment of COPD, which is a serious, chronic disease characterized by a gradual loss of lung function; and AIR parathyroid hormone, a Phase I clinical study product for the treatment of osteoporosis. In addition, the company has an early-stage pipeline focused on various disease areas. Alkermes has collaborations with Eli Lilly and Company; Amylin Pharmaceuticals, Inc.; Cephalon, Inc.; Indevus Pharmaceuticals, Inc.; and Janssen-Cilag. The company was founded in 1987 and is headquartered in Cambridge, Massachusetts. |
2楼2008-05-07 23:00:40
3楼2008-05-08 16:24:00
